Alpenglow Biosciences will host a lunch symposium at ESDR 2026 featuring PD Dr. med. Sandra Schuh of University Hospital Augsburg. The session will explore how 3D imaging can provide a more complete view of inflammatory and neoplastic skin diseases across intact tissue.

Alpenglow joins SPACE-MEL as an associated partner, contributing 3D tissue imaging and AI-driven spatial-analysis expertise to a €5.5 million European doctoral network.

Alpenglow Biosciences is honored to be among the presenting companies at BioCentury Grand Rounds: U.S. 2026, with CEO Nick Reder, MD, MPH, scheduled to present in Seattle on Thursday, June 4, at 10:20 AM.

Alpenglow Biosciences® is now a registered trademark, marking a brand milestone as the company continues advancing 3D spatial biology, whole tissue imaging, and AI powered analysis.

Alpenglow Biosciences will host a SID 2026 lunch symposium featuring Amanda Nelson, PhD, Associate Professor of Dermatology at Penn State College of Medicine. The session will explore how 3D tissue imaging, novel technologies and AI-powered analysis can support a deeper understanding of hidradenitis suppurativa biology.

Aurora Platform enabled 3D tissue imaging and RNA-FISH analysis across full subglottic stenosis biopsies, presented at COSM 2026 by Shikhar Dhingra, MS.

Alpenglow Biosciences has been named a finalist for Innovation of the Year at the 2026 GeekWire Awards, recognizing groundbreaking technology that solves real customer problems and creates meaningful impact.

Alpenglow’s dermatology pipeline will be featured at SID 2026 across studies in burning mouth syndrome and hidradenitis suppurativa using 3D tissue imaging.

The 3D Imaging World Cup 2025 has concluded with powerful datasets, innovative projects, and a global community showcasing the potential of light sheet imaging. Meet the three winning teams and explore the science behind their work.

Alpenglow’s collaboration with VIRDX has been featured on the cover of Fierce Biotech. This recognition highlights how GPU acceleration is powering the next generation of 3D imaging technologies.

Alpenglow Biosciences and Molecular Instruments announce a new partnership to enable full-volume 3D RNA imaging in intact tissues, and celebrate with the launch of the 3D Imaging World Cup 2025.

Alpenglow Biosciences and ZEISS announce a new partnership to co-develop an inverted light-sheet microscope and AI-driven bioinformatics pipeline designed to advance clinical 3D pathology.

Alpenglow Biosciences will highlight 3D pathology innovations for skin disease at SID 2025 as a Gold Sponsor, with a featured symposium on alopecia led by Prof. Maria Hordinsky and Dr. Nicholas Reder.

Join Alpenglow Biosciences at AACR 2025 for a special dinner event featuring Dr. Sammy Ferri-Borgogno on the role of 2D and 3D spatial biology in decoding endometrial cancers.

Alpenglow Biosciences adds industry veterans Blandine Merino and Mike Rice to its Advisory Board to support growth in digital pathology, 3D imaging, and precision medicine.